Workflow
Dolby Laboratories(DLB)
icon
Search documents
Dolby Laboratories(DLB) - 2021 Q4 - Annual Report
2021-11-16 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 24, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 I Dolby DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or ...
Dolby Laboratories(DLB) - 2021 Q3 - Earnings Call Transcript
2021-07-31 19:07
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2021 Results Conference Call July 29, 2021 5:00 PM ET Company Participants Jason Dea - Senior Director of Corporate Finance & IR Kevin Yeaman - President, CEO & Director Lewis Chew - Executive VP & CFO Conference Call Participants Ralph Schackart - William Blair Steven Frankel - Collier Securities James Goss - Barrington Research Paul Chung - JPMorgan Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories conference call discussing ...
Dolby Laboratories(DLB) - 2021 Q3 - Quarterly Report
2021-07-28 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 25, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or other ...
Dolby Laboratories(DLB) - 2021 Q2 - Earnings Call Transcript
2021-05-05 01:10
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2021 Earnings Conference Call May 4, 2021 5:00 PM ET Company Participants Jason Dea - Senior Director of Corporate Finance & IR Kevin J. Yeaman - President, CEO & Director Lewis Chew - Executive VP & CFO Conference Call Participants Ralph Edward Schackart - William Blair & Company L.L.C., Research Division;Partner & Technology Analyst Steven Bruce Frankel - Colliers Securities LLC, Research Division; Senior VP & Director of Research Paul Chung - JPMorgan Chase & Co, Re ...
Dolby Laboratories(DLB) - 2021 Q2 - Quarterly Report
2021-05-03 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 26, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 | --- | --- | --- | --- | --- | --- | |--------|---------------------------------------------|-------------------- ...
Dolby Laboratories(DLB) - 2021 Q1 - Earnings Call Transcript
2021-01-29 04:18
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2021 Earnings Conference Call January 28, 2021 5:00 PM ET Company Participants Jason Dea - Director, Investor Relations Kevin Yeaman - President and Chief Executive Officer Lewis Chew - Executive Vice President and Chief Financial Officer Conference Call Participants Steven Frankel - Colliers Paul Chung - JPMorgan Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by, and welcome to the Dolby Laboratories Conference Call discussing Fis ...
Dolby Laboratories(DLB) - 2021 Q1 - Quarterly Report
2021-01-28 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 25, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 | --- | --- | --- | --- | |------------------------------------------------------------------------------------ ...
Dolby Laboratories(DLB) - 2020 Q4 - Annual Report
2020-11-16 13:30
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 25, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or other ju ...
Dolby Laboratories(DLB) - 2020 Q4 - Earnings Call Transcript
2020-11-13 04:13
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2020 Earnings Conference Call November 12, 2020 5:00 PM ET Company Participants Jason Dea - Director of Corporate Finance and Investor Relations Lewis Chew - Executive Vice President and Chief Financial Officer Kevin Yeaman - President and Chief Executive Officer Conference Call Participants Steven Frankel - Colliers Securities LLC Ralph Schackart - William Blair & Company LLC Paul Chung - JPMorgan Chase & Co. Eric Wold - B. Riley FBR, Inc. James Goss - Barrington Rese ...
Dolby Laboratories(DLB) - 2020 Q3 - Earnings Call Transcript
2020-08-04 02:46
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2020 Earnings Conference Call August 3, 2020 5:00 PM ET Company Participants Jason Dea - Director, Investor Relations Lewis Chew - Executive Vice President and Chief Financial Officer Kevin Yeaman - President and Chief Executive Officer Conference Call Participants Ralph Schackart - William Blair Paul Chung - JP Morgan Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fi ...